Clinical trial
Optimisation of Primary HIV1 Infection Treatment (ANRS 147 OPTIPRIM)
NCT01033760 is registered in ClinicalTrials.gov with ANRS, Emerging Infectious Diseases as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Optimisation of Primary HIV1 Infection Treatment (ANRS 147 OPTIPRIM)
- Lead sponsor
- ANRS, Emerging Infectious Diseases
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- April 30, 2010
- Completion date
- December 31, 2013
- Enrollment
- 90 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hiv-1 infections